Validation of the IASLC Residual Tumor Classification in Patients with Stage III-N2 Non-small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed by Surgery-Reference-Cited by-同舟云学术

Validation of the IASLC Residual Tumor Classification in Patients with Stage III-N2 Non-small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed by Surgery

Published:2022-02-15 Issue: Volume:Publish Ahead of Print Page:
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Lee Junghee,Lee Jin,Hong Yun Soo,Lee Genehee,Kang Danbee,Yun Jeonghee,Jeon Yeong Jeong,Shin Sumin,Cho Jong Ho,Choi Yong Soo,Kim Jhingook,Zo Jae Ill,Shim Young Mog,Guallar Eliseo,Cho Juhee,Kim Hong Kwan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of IASLC 9th Edition TNM Classification for Lung Cancer: Focus on N Descriptor;2024-08-11

2. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the Classification of Residual Tumor After Resection for the Forthcoming (Ninth) Edition of the TNM Classification of Lung Cancer;Journal of Thoracic Oncology;2024-07

3. Defining resectability: When do you try to take it out?;JTCVS Open;2024-06

4. Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification to Upgrade Extracapsular Extension of Tumor in Nodes From R0 to Incomplete Resection;Journal of Thoracic Oncology;2024-01

5. Residual tumor descriptors proposed by the International Association for the Study of Lung Cancer may not be applicable to stage I and ground-glass opacity-featured non-small cell lung cancer;Translational Lung Cancer Research;2023-11